MedTrace Logo

Intestinal and Humoral Immunity of Sequential Polio Vaccination Schedules

NCT02412514 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 456

Last updated 2016-07-20

No results posted yet for this study

Summary

This is a phase IV open-label randomized clinical trial that will compare intestinal and humoral immunity in infants receiving inactivated poliovirus vaccine (IPV) and two or three doses of bivalent oral poliovirus vaccine (bOPV).

Conditions

  • Poliomyelitis

Interventions

BIOLOGICAL

bOPV (three dose)

bOPV administered at 6, 10, and 14 weeks of age.

BIOLOGICAL

bOPV (two dose)

bOPV administered at 10 and 14 weeks of age.

BIOLOGICAL

IPV

IPV administered at 6 weeks of age

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Weeks
Max Age
6 Weeks
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Bangladesh

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02412514 on ClinicalTrials.gov